Si prevede che il mercato del microbioma umano raggiungerà i 2.921,68 milioni di dollari entro il 2028 rispetto ai 718,95 milioni di dollari del 2021; si stima che crescerà a un CAGR del 22,2% nel corso del 2021-2028.
Il microbiota umano è costituito da trilioni di cellule microbiche simbiotiche ospitate da ogni persona, principalmente batteri nell'intestino. I microbi, inclusi batteri, funghi e virus, sono agenti patogeni che si accumulano nel tempo e l’habitat nell’intestino trasforma le loro attività genetiche e i processi metabolici, determinando una risposta immunitaria anormale contro le sostanze e i tessuti normalmente presenti nell’intestino. il corpo umano. Diversi progetti sul microbioma sono stati lanciati in tutto il mondo con l’obiettivo di comprendere il ruolo svolto da questi simbionti e il loro impatto sulla salute dell’ospite umano. La crescita del mercato del microbioma umano è attribuita a fattori quali la crescente incidenza delle malattie legate allo stile di vita, la crescente attenzione alle terapie del microbioma umano e i crescenti progressi tecnologici nella metagenomica e nel sequenziamento di prossima generazione. Tuttavia, le rigide linee guida governative e la mancanza di conoscenza di un esame dettagliato ostacolano la crescita del mercato.
Regioni redditizie per il mercato del microbioma umano
Mercato Approfondimenti
Aumento dell'incidenza delle malattie legate allo stile di vita
Negli ultimi decenni, i ricercatori hanno fatto chiarezza sulla relazione tra microbioma umano e malattie legate allo stile di vita come cancro, diabete, obesità, e depressione. I cambiamenti negli stili di vita e nelle norme sociali influenzano il microbioma in ogni fase della vita. L’alterazione del microbioma umano può aiutare a eliminare tali malattie legate allo stile di vita. Secondo l'Organizzazione Mondiale della Sanità, nel 2016 il 13% della popolazione mondiale (adulti) era obesa. Secondo "La nuova era del trattamento dell'obesità e dei disturbi metabolici: prove e aspettative per il trapianto di microbioma intestinale", pubblicato nel 2016, i microbi che risiedono nel tratto gastrointestinale umano agiscono come un organo endocrino la cui composizione e funzionalità contribuiscono allo sviluppo dell’obesità. Pertanto, il trapianto di microbioma fecale/intestino (GMT), che prevede il trasferimento di feci da un donatore sano al paziente, è un potenziale trattamento per l’obesità.
Il diabete è una delle emergenze sanitarie globali del 21esimo secolo. Secondo l’International Diabetes Federation (IDF), nel 2017 il numero di persone affette da diabete in Nord America ammontava a circa 46 milioni e si prevede che salirà a 62 milioni entro il 2045, con una prevalenza della malattia pari a circa il 35% durante il 2017. periodo di previsione. I livelli ridotti di Firmicutes Clostridia indicano il microbioma dei pazienti con batteri diabetici produttori di butirrato e un rapporto aumentato di Bacteroidetes: Firmicutes. Pertanto, il diabete può essere prevenuto e trattato alterando il microbioma mediante la somministrazione di prebiotici, probiotici e il trapianto fecale. Pertanto, la crescente incidenza di malattie croniche legate allo stile di vita sta guidando la crescita del mercato del microbioma umano.
Approfondimenti basati sul prodotto
Basati sul prodotto, l'essere umano Il mercato del microbioma è segmentato in alimenti, alimenti medici, probiotici, prebiotici, farmaci, dispositivi diagnostici e integratori. Si prevede che il segmento dei probiotici deterrà la quota di mercato maggiore nel 2021 e si prevede che il segmento dei prebiotici registrerà il CAGR più elevato sul mercato durante il periodo di previsione.
Umano Mercato del microbioma, per prodotto: 2021 e 2028
Copertura del rapporto
Approfondimenti basati sulla malattia
Il mercato del microbioma umano, per malattia, è segmentato in diabete, cancro , disturbi autoimmuni, obesità, disturbi mentali e altre malattie. Il mercato del microbioma umano sta emergendo a causa della crescente incidenza di malattie legate allo stile di vita come il cancro e il diabete. Si prevede che il segmento dell'obesità deterrà la quota maggiore del mercato nel 2021, mentre si stima che il segmento del diabete registrerà il CAGR più elevato durante il periodo di previsione.
Applicazione- Approfondimenti basati
Il mercato del microbioma umano, per applicazione, è segmentato in diagnostico e terapeutico. Si prevede che il segmento terapeutico deterrà una quota di mercato maggiore nel 2021 e si stima inoltre che registrerà un CAGR più elevato durante il periodo di previsione.
Approfondimenti strategici
Il lancio e l'approvazione dei prodotti sono le strategie comunemente adottate dalle aziende per espandere la propria presenza globale e i portafogli di prodotti. Le aziende nel mercato del microbioma umano si concentrano sulla strategia di collaborazione per ampliare la propria clientela, il che, a sua volta, consente loro di mantenere il proprio marchio in tutto il mondo.
Microbioma umano Mercato: per prodotto
- Probiotici
- Alimenti
- Prebiotici
- Alimenti medicali
- Dispositivi diagnostici
- Farmaci
- Integratori
Mercato del microbioma umano: per malattia
- Obesità
- Diabete
- Disturbi autoimmuni
- Cancro
- Disturbi mentali< /li>
- Altro
Mercato del microbioma umano - per applicazione
- Terapeutica
- Diagnostica
Mercato del microbioma umano: per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'Asia Pacifico
- Medio Oriente e Africa (MEA)
- Sudafrica
- Arabia Saudita
- Emirati Arabi Uniti
- Resto del Medio Oriente e dell'Africa
- Sud e America Centrale (SCAM)
- Brasile
- Argentina
- Resto dell'America centrale e meridionale
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Synthetic Biologics Inc.
- DuPont
- MaaT Pharma
- Eligo Bioscience
- Merck & Co. Inc
- AOBiome LLC
- Kaleido
- Seres Therapeutics
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Asia Pacific human microbiome market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The rise in the collaborations among the Asian countries and Western countries for the research activities and the extensive genomic research in China are to likely drive the human microbiome market in the forecast period. In May 2018, The Conference on Human Microbiome and Chronic Disease, hosted by the Institute of Microbiology, Chinese Academy of Sciences and Chinese Society of Biotechnology was held in China National Convention Center at Beijing. The aim was to promote research human microbiome and related technology. Thus, there is a huge potential for human microbiome market in the region during the forecast period owing to the above-mentioned factors.
The growth of the human microbiome market is attributed to the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However strict government guidelines and lack of knowledge about detailed examination hinders the market growth.
The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body.
The List of Companies - Human Microbiome Market
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Synthetic Biologics Inc.
- DuPont
- MaaT Pharma
- Eligo Bioscience
- Merck & Co. Inc
- AOBiome LLC
- Kaleido
- Seres Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Aug 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Aug 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Aug 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)